Dr. Brawer on the Significance of the Prolaris Genetic Test for Prostate

Michael Brawer, MD
Published: Wednesday, Aug 16, 2017



Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the significance of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

This was significant because we are moving more towards the utilization of active surveillance in the United States, explains Brawer. With the statistics involving African Americans, it is important to know whether tests are reliable. With respect to Prolaris, it was necessary to determine if the test worked for all patient populations, states Brawer.



Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the significance of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

This was significant because we are moving more towards the utilization of active surveillance in the United States, explains Brawer. With the statistics involving African Americans, it is important to know whether tests are reliable. With respect to Prolaris, it was necessary to determine if the test worked for all patient populations, states Brawer.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x